FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2075047100> ?p ?o ?g. }

• W2075047100 endingPage "1509" @default.
• W2075047100 startingPage "1501" @default.
• W2075047100 abstract "Since the development of synthetic somatostatin analogues, several therapeutic applications for somatostatin receptor agonist molecules have been defined. Established applications for somatostatin analogue treatment include pituitary tumours (growth hormone and thyrotropin-secreting adenomas), neuroendocrine tumours of the pancreas and gastrointestinal tract (so-called carcinoid tumours, vasoactive intestinal tumours) and gastroenterological conditions (pancreatitis, gastrointestinal bleedings, refractory diarrhoeas, pancreatic and intestinal fistulas, diarrhoea in AIDS). Further areas for development of somatostatin analogue therapy include obesity, polycystic ovary syndrome and diabetes mellitus, dysmetabolic conditions that are often interrelated. The challenge for the future will be to transform results from clinical trials conducted in heterogeneous clinical situations into novel options of somatostatin analogue use. Since obesity and diabetes mellitus both are disorders of marked heterogeneity, the subgroup of patients that will benefit most from somatostatin analogue treatment has yet to be defined. In addition, the development of more universal ligands covering all of the known somatostatin receptor molecules as well as receptor subtype specific agents is currently underway. The establishment of slow-release depot formulations of octreotide and lanreotide has already provided a more acceptable and consistent delivery mechanism. Use of biodegradable polymer microsphere formulations provides the basis for the development of novel applications, which include hyperinsulinaemia, obesity and polycystic ovary syndrome as components of the dysmetabolic syndrome. The most developed thus far is the use of octreotide in hyperinsulinaemic forms of obesity and in distinct stages of diabetic retinopathy." @default.
• W2075047100 created "2016-06-24" @default.
• W2075047100 creator A5001086144 @default.
• W2075047100 date "2003-09-01" @default.
• W2075047100 modified "2023-10-14" @default.
• W2075047100 title "The therapeutic potential of somatostatin receptor ligands in the treatment of obesity and diabetes" @default.
• W2075047100 cites W1489925379 @default.
• W2075047100 cites W1544564931 @default.
• W2075047100 cites W1561443084 @default.
• W2075047100 cites W1927710737 @default.
• W2075047100 cites W1966728418 @default.
• W2075047100 cites W1975169081 @default.
• W2075047100 cites W1976010697 @default.
• W2075047100 cites W1983196167 @default.
• W2075047100 cites W1983652310 @default.
• W2075047100 cites W1986991414 @default.
• W2075047100 cites W1994594825 @default.
• W2075047100 cites W1997233851 @default.
• W2075047100 cites W1999105502 @default.
• W2075047100 cites W2000637330 @default.
• W2075047100 cites W2009276944 @default.
• W2075047100 cites W2014977165 @default.
• W2075047100 cites W2023584393 @default.
• W2075047100 cites W2030332608 @default.
• W2075047100 cites W2041580344 @default.
• W2075047100 cites W2047177735 @default.
• W2075047100 cites W2050874020 @default.
• W2075047100 cites W2057224051 @default.
• W2075047100 cites W2063446370 @default.
• W2075047100 cites W2069936148 @default.
• W2075047100 cites W2071196890 @default.
• W2075047100 cites W2077815106 @default.
• W2075047100 cites W2085190168 @default.
• W2075047100 cites W2087323715 @default.
• W2075047100 cites W2087571358 @default.
• W2075047100 cites W2094672900 @default.
• W2075047100 cites W2095267515 @default.
• W2075047100 cites W2099344738 @default.
• W2075047100 cites W2115315666 @default.
• W2075047100 cites W2120492671 @default.
• W2075047100 cites W2120663839 @default.
• W2075047100 cites W2137893922 @default.
• W2075047100 cites W2139407501 @default.
• W2075047100 cites W2139695454 @default.
• W2075047100 cites W2141662760 @default.
• W2075047100 cites W2143754781 @default.
• W2075047100 cites W2150452329 @default.
• W2075047100 cites W2166237661 @default.
• W2075047100 cites W2168780440 @default.
• W2075047100 cites W2322634847 @default.
• W2075047100 cites W2323202746 @default.
• W2075047100 cites W2324588265 @default.
• W2075047100 cites W2337454357 @default.
• W2075047100 cites W4210962615 @default.
• W2075047100 cites W4230503343 @default.
• W2075047100 cites W4242855472 @default.
• W2075047100 cites W4249310407 @default.
• W2075047100 doi "https://doi.org/10.1517/13543784.12.9.1501" @default.
• W2075047100 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12943494" @default.
• W2075047100 hasPublicationYear "2003" @default.
• W2075047100 type Work @default.
• W2075047100 sameAs 2075047100 @default.
• W2075047100 citedByCount "21" @default.
• W2075047100 countsByYear W20750471002012 @default.
• W2075047100 countsByYear W20750471002013 @default.
• W2075047100 countsByYear W20750471002018 @default.
• W2075047100 countsByYear W20750471002019 @default.
• W2075047100 countsByYear W20750471002020 @default.
• W2075047100 countsByYear W20750471002022 @default.
• W2075047100 countsByYear W20750471002023 @default.
• W2075047100 crossrefType "journal-article" @default.
• W2075047100 hasAuthorship W2075047100A5001086144 @default.
• W2075047100 hasConcept C126322002 @default.
• W2075047100 hasConcept C134018914 @default.
• W2075047100 hasConcept C2776297358 @default.
• W2075047100 hasConcept C2777391703 @default.
• W2075047100 hasConcept C2777433750 @default.
• W2075047100 hasConcept C2778764654 @default.
• W2075047100 hasConcept C2779066768 @default.
• W2075047100 hasConcept C2779609023 @default.
• W2075047100 hasConcept C2781025020 @default.
• W2075047100 hasConcept C2984496839 @default.
• W2075047100 hasConcept C3018442814 @default.
• W2075047100 hasConcept C555293320 @default.
• W2075047100 hasConcept C71315377 @default.
• W2075047100 hasConcept C71924100 @default.
• W2075047100 hasConcept C80115893 @default.
• W2075047100 hasConceptScore W2075047100C126322002 @default.
• W2075047100 hasConceptScore W2075047100C134018914 @default.
• W2075047100 hasConceptScore W2075047100C2776297358 @default.
• W2075047100 hasConceptScore W2075047100C2777391703 @default.
• W2075047100 hasConceptScore W2075047100C2777433750 @default.
• W2075047100 hasConceptScore W2075047100C2778764654 @default.
• W2075047100 hasConceptScore W2075047100C2779066768 @default.
• W2075047100 hasConceptScore W2075047100C2779609023 @default.
• W2075047100 hasConceptScore W2075047100C2781025020 @default.
• W2075047100 hasConceptScore W2075047100C2984496839 @default.
• W2075047100 hasConceptScore W2075047100C3018442814 @default.

• next